Navigation Links
ActX Bridges the Gap Between Better Patient Care and Current Physician Genetic Knowledge
Date:8/9/2018

ActX introduces GenoACT(sm), a Genetic Clinical Decision Support Service. The GenoACT service was developed and is continually updated by a talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by machine learning (AI). The integrated service provides:
1. Information on the medical impact of a patient’s genetic variants
2. Educational information for clinicians, with references
3. Actionable clinical recommendations to address the variants    

GenoACT covers the key clinically relevant areas of pharmacogenomics, hereditary risk and carrier status. Integrated into the Electronic Health Record (EHR), GenoACT blends seamlessly into normal workflow. By providing actionable information only as it is needed, GenoACT prevents the common problem of physician information overload. GenoACT actively checks prescriptions as they are written and identifies ineffective medications, potential adverse reactions, and dosing considerations. For actionable hereditary risk and carrier status, physicians are alerted in their normal clinical inbox initially and over time as new research uncovers potentially serious risks for all patient variants on file.

Most major EHR vendors (10 in total) have chosen to integrate the ActX Service within their EHRs. They have identified the value to health systems and physician practices of making precision medicine a core part of physician workflow, using the functionality of GenoACT.

Dr. Andrew Ury, founder of ActX explained: “As a working physician I recognized early in my career how difficult it was to stay on top of all the latest research. As Precision Medicine has evolved the clinical research on the use of a patient’s genetic variants has exploded and the knowledge gap has become a major stumbling block. By incorporating GenoACT into a clinician’s normal daily work flow, we have finally found a way to bridge this gap, through the use of up to date integrated, actionable, clinical decision support.”

About ActX:
Founded in 2012, ActX helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. Integrated into a physician’s normal software tools (the electronic medical record) and workflow, ActX analyzes the patient’s genetic information in real time and, for example, alerts the physician if a medication is unlikely to be effective or will cause side effects. ActX can also warn the physician about serious, actionable medical risks. For more information about ActX and taking the next step towards precision medicine, visit us at http://www.actx.com, contact us at info(at)actx.com or call 888-998-2289.

Read the full story at https://www.prweb.com/releases/actx_bridges_the_gap_between_better_patient_care_and_current_physician_genetic_knowledge/prweb15679107.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
2. Autonomous energy-scavenging micro devices will test water quality, monitor bridges, more
3. SynCardia Total Artificial Heart Bridges Mother of Four with Congenital Heart Defect & Biventricular Heart Failure to Transplant
4. Single-Tooth Implants and Dental Bridges Market Worth $4,690 Million by 2019 - New Report by MarketsandMarkets
5. Dental Bridges and Single-Tooth Implants Market Hit to $4,690 Million by 2019 - New Research Report by MarketsandMarkets
6. Partnership between EBSCO Publishing and BioOne Online Journals Adds Scholarly Biological, Ecological and Environment Sciences Articles to EBSCO Discovery Service™
7. Probiotic Action Shares New Insight on the Link Between Sugar, Probiotics, and Acne
8. Probiotic Action Explains the New Link Between Probiotics, Bacteria and Eczema
9. Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers
10. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
11. Natural Acne Remedy, Probiotic Action Sheds Industry Insight on the Connection between Dairy and Acne
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... ... ... Renowned Honolulu veterinarian, Dr. Patrick Leadbeater, has begun offering VetStem Regenerative ... Kahala Pet Hospital on Oahu, is a skilled surgeon who has been ... of Kauai on an almost weekly basis to perform surgery at Kapaa Animal ...
(Date:11/13/2018)... ... 12, 2018 , ... Dr. Dan Myers, a well-respected regional ... welcomes new patients for MTM® Clear Aligners. Offering a variety of orthodontics solutions, ... the Sandy Springs and Alpharetta areas. Constantly on the forefront of innovative dental ...
(Date:11/13/2018)... Calif. (PRWEB) , ... November 13, 2018 , ... , ... Beijing Office in China. With the increasingly growing demand for AFM technology in China, ... and industrial communities by opening an office in Beijing equipped with Park AFM. , ...
(Date:11/11/2018)... ... 2018 , ... Triple W, an innovator of connected health devices, today announced ... DFree ®, the first health tech wearable device for incontinence that monitors how ... bathroom. The announcement was made during CES Unveiled New York, an invite-only tech event ...
Breaking Biology Technology:
(Date:12/13/2018)... ... December 12, 2018 , ... NDA Partners Chief Executive ... prominent Expert Consultants, was recently honored by the American Association of Pharmaceutical Scientists ... in pharmaceutical science, technology, engineering, or education and whose contributions to the pharmaceutical ...
(Date:12/13/2018)... Fla. (PRWEB) , ... December 12, 2018 , ... New ... preventing the growing problem of drowsy and distracted driving, one of the main causes ... under the guidance of Dr. Kanwal Gagneja , assistant professor of computer science, ...
(Date:12/10/2018)... ... December 10, 2018 , ... Today, RoosterBio Inc. and ... goal of accelerating the development of the Regenerative Medicine field. This alliance ... technology around human umbilical cord perivascular cells (HUCPVCs). Together, it is anticipated ...
Breaking Biology News(10 mins):